Healthcare & Life Sciences
ParcelBio
United Statesparcelbio.com
ParcelBio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
2021
Founded
1
Investors
About ParcelBio
ParcelBio is a company founded in 2021 headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ParcelBio develops a proprietary mRNA platform, APEXm™, that enhances protein expression potency and durability to enable durable mRNA medicines for applications including in vivo CAR-T therapies, oncology, autoimmune diseases, and therapeutic protein delivery.
Explore ParcelBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.